Amgen, a leading biopharmaceutical company, has recently transitioned its enterprise AI tool from Microsoft's Copilot to OpenAI's ChatGPT. This strategic shift underscores the intensifying competition between Microsoft and OpenAI in the enterprise AI market.
Amgen's decision to adopt ChatGPT was...
ai adoption
ai competition
ai ecosystem
aiin research
aiinnovation
aiintegration
ai market trends
ai platform connections
ai technology advancement
aitoolsinbusinessai usability
ai user experience
biopharmaceutical ai
chatgpt
corporate ai strategy
enterprise ai
enterprise software
microsoft copilot
openai
